Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure. 2014

Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan; Genomics Research Center, Academia Sinica, Taipei, Taiwan; Molecular and Genomic Epidemiology Center, China Medical University Hospital, Taichung, Taiwan; China Medical University, Taichung, Taiwan.

BACKGROUND Arsenic is a well-documented carcinogen of human urothelial carcinoma (UC) with incompletely understood mechanisms. OBJECTIVE This study aimed to compare the genome-wide DNA methylation profiles of arsenic-induced UC (AsUC) and non-arsenic-induced UC (Non-AsUC), and to assess associations between site-specific methylation levels and cumulative arsenic exposure. METHODS Genome-wide DNA methylation profiles in 14 AsUC and 14 non-AsUC were analyzed by Illumina Infinium methylation27 BeadChip and validated by bisulfite pyrosequencing. Mean methylation levels (β¯) in AsUC and non-AsUC were compared by their ratio (β¯ ratio) and difference (Δβ¯). Associations between site-specific methylation levels in UC and cumulative arsenic exposure were examined. RESULTS Among 27,578 methylation sites analyzed, 231 sites had β¯ ratio >2 or <0.5 and 45 sites had Δβ¯ >0.2 or <-0.2. There were 13 sites showing statistically significant (q<0.05) differences in β¯ between AsUC and non-AsUC including 12 hypermethylation sites in AsUC and only one hypermethylation site in non-AsUC. Significant associations between cumulative arsenic exposure and DNA methylation levels of 28 patients were observed in nine CpG sites of nine gens including PDGFD (Spearman rank correlation, 0.54), CTNNA2 (0.48), KCNK17 (0.52), PCDHB2 (0.57), ZNF132 (0.48), DCDC2 (0.48), KLK7 (0.48), FBXO39 (0.49), and NPY2R (0.45). These associations remained statistically significant for CpG sites in CTNNA2, KLK7, NPY2R, ZNF132 and KCNK17 in 20 non-smoking women after adjustment for tumor stage and age. CONCLUSIONS Significant associations between cumulative arsenic exposure and methylation level of CTNNA2, KLK7, NPY2R, ZNF132 and KCNK17 were found in smoking-unrelated urothelial carcinoma. Arsenic exposure may cause urothelial carcinomas through the hypermethylation of genes involved in cell adhesion, proteolysis, transcriptional regulation, neuronal pathway, and ion transport. The findings of this study, which are limited by its small sample size and moderate dose-response relation, remain to be validated by further studies with large sample sizes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001151 Arsenic A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed) Arsenic-75,Arsenic 75
D014571 Urologic Neoplasms Tumors or cancer of the URINARY TRACT in either the male or the female. Cancer of Urinary Tract,Urinary Tract Cancer,Urologic Cancer,Cancer of the Urinary Tract,Neoplasms, Urologic,Urinary Tract Neoplasms,Urological Cancer,Urological Neoplasms,Cancer, Urinary Tract,Cancer, Urologic,Cancer, Urological,Cancers, Urinary Tract,Cancers, Urologic,Cancers, Urological,Neoplasm, Urinary Tract,Neoplasm, Urologic,Neoplasm, Urological,Neoplasms, Urinary Tract,Neoplasms, Urological,Tract Neoplasm, Urinary,Tract Neoplasms, Urinary,Urinary Tract Cancers,Urinary Tract Neoplasm,Urologic Cancers,Urologic Neoplasm,Urological Cancers,Urological Neoplasm

Related Publications

Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
January 2010, Cancer science,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
December 2013, Cancer science,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
December 2022, Ecotoxicology and environmental safety,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
October 2018, Environment international,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
August 2014, Journal of developmental origins of health and disease,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
December 2018, The Science of the total environment,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
July 2022, Environmental pollution (Barking, Essex : 1987),
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
June 2012, Epigenetics & chromatin,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
December 2014, Experimental and molecular pathology,
Tse-Yen Yang, and Ling-I Hsu, and Allen W Chiu, and Yeong-Shiau Pu, and Sheng-Hsin Wang, and Ya-Tang Liao, and Meei-Maan Wu, and Yuan-Hung Wang, and Chin-Hao Chang, and Te-Chang Lee, and Chien-Jen Chen
January 2023, Psychiatry and clinical neurosciences,
Copied contents to your clipboard!